Q2 2021 Gossamer Bio Inc Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Gossamer Bio Q2 Earnings Call. (Operator Instructions)
And I would now like to turn the call over to your first speaker, Bryan Giraudo, Chief Financial Officer. You may begin your conference.
Thank you, operator, and thank you all for joining us this afternoon. I'm joined on today's call by Gossamer Bio's Chairman, Co-Founder and Chief Executive Officer, Faheem Hasnain; Richard Aranda, Gossamer Bio's Chief Medical Officer; as well as Laura Carter, Gossamer Bio's Chief Scientific Officer.
Earlier this afternoon, Gossamer Bio issued a press release announcing its financial results for the second quarter ended June 30, 2021, in addition to providing a corporate update.
Please note that certain information discussed on the call today is covered under the safe harbor provision of the Private Securities Litigation Reform Act. We caution listeners that during this call, Gossamer management will be making forward-looking statements. Actual
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
